Abstract | OBJECTIVE: DESIGN: We studied 60 gerbils for 18 months and left five animals uninfected (control group), inoculated 55 with H. pylori, and treated 28 of the infected animals with netazepide (Hp+YF476 group). Twenty-seven infected animals were given no treatment (Hp group). We measured plasma gastrin and intraluminal pH. H. pylori detection and histologic evaluations of the stomach were carried out. RESULTS: All 55 inoculated animals were H. pylori positive at termination. Eighteen animals in the Hp group had gastritis. There was a threefold increase in mucosal thickness in the Hp group compared to the Hp+YF476 group, and a threefold increase in oxyntic neuroendocrine cells in the Hp group compared to the Hp+YF476 group (p < .05). All animals in the Hp+YF476 group had macro- and microscopically normal findings in the stomach. Plasma gastrin was higher in the Hp group than in the control group (172 ± 16 pmol/L vs 124 ± 5 pmol/L, p < .05) and highest in the Hp+YF476 group (530 ± 36 pmol/L). Intraluminal pH was higher in the Hp group than in the Hp+YF476 group (2.51 vs 2.30, p < .05). CONCLUSION: The gastrin antagonist netazepide prevents H. pylori-induced gastritis in Mongolian gerbils. Thus, gastrin has a key role in the inflammatory reaction of the gastric mucosa to H. pylori infection in this species.
|
Authors | Øystein Sørdal, Helge Waldum, Ivar S Nordrum, Malcolm Boyce, Kåre Bergh, Bjørn Munkvold, Gunnar Qvigstad |
Journal | Helicobacter
(Helicobacter)
Vol. 18
Issue 6
Pg. 397-405
(Dec 2013)
ISSN: 1523-5378 [Electronic] England |
PMID | 23865485
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 John Wiley & Sons Ltd. |
Chemical References |
- Benzodiazepinones
- Phenylurea Compounds
- Receptor, Cholecystokinin B
- YF 476
|
Topics |
- Animals
- Benzodiazepinones
(administration & dosage)
- Disease Models, Animal
- Gastric Mucosa
(drug effects, immunology, microbiology)
- Gerbillinae
- Helicobacter Infections
(drug therapy, immunology, microbiology, prevention & control)
- Helicobacter pylori
(drug effects, physiology)
- Humans
- Male
- Phenylurea Compounds
(administration & dosage)
- Receptor, Cholecystokinin B
(antagonists & inhibitors, immunology)
|